Mark Eisner

Chief Medical Officer at FibroGen, Inc.

Mark Eisner

Mark Eisner

Chief Medical Officer at FibroGen, Inc.

Biography

Mark Eisner, M.D., M.P.H.

Chief Medical Officer

Dr. Eisner, Chief Medical Officer, joined the Company in December of 2020. Dr. Eisner oversees all global clinical development and regulatory affairs for FibroGen. Dr. Eisner brings nearly 30 years of academic, biopharmaceutical, and drug development experience, from early clinical phase through post-commercialization. Prior to joining FibroGen, Dr. Eisner was at Genentech, a member of the Roche Group, and was Senior Vice President and Global Head of Product Development Immunology, Infectious Disease, and Ophthalmology. He also served on the Board of the Genentech Foundation, a private charitable foundation that supports educational and community organizations.

Prior to Genentech, Mark was Professor of Medicine and Anesthesia at the University of California San Francisco. Dr. Eisner received an A.B. degree from Stanford University in Human Biology and then received his M.D. degree from the University of Pennsylvania School of Medicine. He completed residency training in internal medicine, served as Chief Medical Resident, and pursued advanced fellowship training in pulmonary and critical care medicine at the University of California, San Francisco. He also received a M.P.H. degree from the University of California, Berkeley School of Public Health.

Overview
RelSci Relationships

807

Number of Boards

1

Relationships
RelSci Relationships are individuals Mark Eisner likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer at FibroGen, Inc.

Relationship likelihood: Strong

Interim President at FibroGen, Inc.

Relationship likelihood: Strong

Executive Director, Clinical Development at FibroGen, Inc.

Relationship likelihood: Strong

Chief Financial Officer & Chief Accounting Officer at FibroGen, Inc.

Relationship likelihood: Strong

Chief Commercial Officer at FibroGen, Inc.

Relationship likelihood: Strong

Executive Director at FibroGen, Inc.

Relationship likelihood: Strong

Executive Director at FibroGen, Inc.

Relationship likelihood: Strong

Counsel at Goodwin Procter LLP

Relationship likelihood: Strong

Chief Scientific Officer at FibroGen, Inc.

Relationship likelihood: Strong

Chief Medical Officer at FibroGen, Inc.

Relationship likelihood: Strong

Paths to Mark Eisner
Potential Connections via
Relationship Science
You
Mark Eisner
Chief Medical Officer at FibroGen, Inc.
Education

Stanford University, located between San Francisco and San Jose in the heart of California's Silicon Valley, is one of the world's leading teaching and research universities. Since its opening in 1891, Stanford has been dedicated to finding solutions to big challenges and to preparing students for leadership in a complex world.

The UC Berkeley School of Public Health is highly regarded for the quality of its faculty and students and has a reputation for excellence in education, research, and community engagement. More than 12,000 graduates have put their education and skills into practice in public health worldwide. Our alumni are transformational leaders across all health sectors, with a legacy of impact and innovation locally and globally.

Career History
Chief Medical Officer
2020 - Current

FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993 and is headquartered in San Francisco, CA.

Public Holdings
Restricted data only for RelSci Professional users.
Other Affiliations

Mark Eisner is affiliated with FibroGen, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Mark Eisner. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Mark Eisner's profile does not indicate a business or promotional relationship of any kind between RelSci and Mark Eisner.